FROM OUR PARTNER
Could This Company Do for Housing What Tesla Did for Cars?
Most car factories like Ford or Tesla build a car every minute. Isn’t it time we did the same for homes?
BOXABL aims to disrupt the $1T construction industry by bringing assembly line automation to housing. After early orders from SpaceX and the U.S. Department of Defense, they’ve streamlined production and are now delivering to both developers and consumers. They’ve also reserved the ticker BXBL on Nasdaq.*
Since 2020, BOXABL has raised over $170M from 40,000+ investors and recently passed 50% of their Reg A+ funding cap. Investments are now only accepted through their website until it’s full.
Invest now before it’s too late.
|
🤝 US and China suspend tariffs for 90 days
LINK
|
- The United States and China consented to halt most mutual tariffs for a ninety-day window, providing time for ongoing trade discussions following recent talks between the nations.
- This temporary agreement lessens immediate economic instability for technology companies, especially those with substantial manufacturing operations based in China previously subject to high import duties.
- Despite the truce, an expert warns that the tech industry is not entirely free from potential trade friction, awaiting clarity on future US levies for specific electronic components.
|
💥 OpenAI is negotiating with Microsoft to launch a future IPO
LINK
|
- OpenAI and Microsoft are reportedly discussing alterations to their existing partnership, which could pave the way for the artificial intelligence company's future initial public offering.
- Having invested significantly, the software corporation might trade some equity in OpenAI's for-profit entity for continued access to sophisticated AI systems developed beyond their current agreement.
- These crucial conversations occur as the AI research lab considers adjustments to its operational framework and contemplates an eventual transition to becoming a publicly traded entity.
|
📱 Apple reportedly plans to hike prices of upcoming iPhones
LINK
|
- Sources indicate Apple might increase the retail price for its upcoming iPhone 17 models, potentially bundling this change with fresh capabilities and aesthetic modifications this fall.
- The company is reportedly keen to avoid any perception that potential cost adjustments are a direct consequence of the U.S. tariff still affecting smartphones from China.
- Amid trade tensions, Apple has bolstered inventory and relocated some production for the U.S. market to India, though high-end models remain largely China-produced due to scale needs.
|
⚡ China develops silicon-free transistor claimed fastest ever
LINK
|
- Scientists in China have developed a silicon-free transistor featuring full gate coverage, which they assert significantly outperforms existing semiconductor technology in speed and efficiency benchmarks.
- This novel component, constructed using bismuth-based materials, reportedly operates 40% quicker than Intel's latest 3nm chips while utilizing 10% less power during operation tests.
- The Peking University research team claims their innovative device offers enhanced current control and could potentially be integrated into current fabrication facilities for future microprocessors.
|
🧑💼 Klarna brings back human staff after AI provides lower quality
LINK
|
- Klarna initially replaced employees with artificial intelligence for customer service tasks but found the automated system delivered a significantly lower quality of support compared to people.
- The company is now actively recruiting human staff members again, guaranteeing customers can always choose to speak with a real person when they require assistance or help.
- Acknowledging that cost-cutting led to poorer service, Klarna's leadership stated that investing in the quality of human support represents the firm's path forward for interactions.
|
💰 Elizabeth Holmes partner reportedly raises millions for new blood testing startup
LINK
|
- Billy Evans, the partner of convicted Theranos founder Elizabeth Holmes, is reportedly securing millions in funding for his new health technology venture named Haemanthus.
- Promotional information and a patent detail a device purportedly able to analyze blood, saliva, and urine samples rapidly to identify biomarkers like glucose and hormones.
- This Haemanthus system plans to employ deep learning models for detecting conditions including cancer and infections, starting with pet healthcare before eventual human application.
|
|
